高级检索
当前位置: 首页 > 详情页

Renoprotective effect of atorvastatin on STZ-diabetic rats through inhibiting inflammatory factors expression in diabetic rat

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Nephrology, Mian Yang Central Hospital, Fucheng District, Mianyang, Sichuan, China [2]Department of Nephrology, Jiang You People’s Hospital, Jiangyou, Sichuan, China [3]Department of Nephrology, First People’s Hospital of Yun Nan Province, Kunming, Yun Nan, China
出处:
ISSN:

关键词: Diabetic kidney disease (DKD) Atorvastatin Inflammatory response

摘要:
OBJECTIVE: Though increasing evidences showed that statins had potential benefits to diabetic kidney disease (DKD), its mechanism has not been completely elucidated yet. The aim of this study was to investigate the renoprotective effects of atorvastatin on DKD. MATERIALS AND METHODS: Kidney injury was induced by streptozotocin (STZ) in rats. STZ-diabetic rats were treated with atorvastatin (10 mg/kg/d) for consecutive 8 weeks. Renal functional and morphological changes were evaluated by clinical biochemistry and histological examination. The expression of inflammatory factors in kidney was measured by real-time (RT)-PCR and enzyme-linked immunosorbent assay (ELISA). RESULTS: Compared with DKD rat, atorvastatin effectively reduced the levels of low-density lipoprotein cholesterol (LDL-C), creatinine (CREA), ratio of urine albumin to creatinine (UACR) (p < 0.05). The expression of inflammatory factors TNF-a, MCP-1 and IL-6 in kidney tissue were significantly down-regulated, as well (p < 0.05). Atorvastatin improved kidney injury with the reduced morphologic lesions and renal fibrosis and the increasing transforming growth factor-beta (TGF-beta) and collagen I staining. CONCLUSIONS: Our results suggested that atorvastatin could ameliorate DKD through inhibiting pro-inflammatory pathways. Atorvastatin may possess a potential antidiabetic effect and serve as the therapeutic drug for DKD management.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 药学
JCR分区:
出版当年[2015]版:
Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Department of Nephrology, Mian Yang Central Hospital, Fucheng District, Mianyang, Sichuan, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82325 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号